Jul 2026· British Journal of Pharmacology· 0 citations· 52 references
Medicine
TL;DR
The presented flux-based approaches have the advantage to address pre-equilibrium as well as equilibrium conditions and can be applied to any ligand-binding model.
Abstract
Background
AND
Purpose
Binding kinetics are essentially based on rate constants. Yet, this view has been challenged by the idea that 'binding fluxes' are dynamic and therefore more relevant. Those fluxes refer to the rate at which a target/receptor changes from one state into another through ligand/drug binding or a conformational change. Besides acting as building blocks for many algebraic expressions, they also determine how the concentration of each individual target state evolves over time. Here we show that such fluxes offer additional opportunities for understanding and predicting ligand binding.
EXPERIMENTAL APPROACH
Simulated binding data are obtained by solving the relevant set of flux-based differential equations for increasingly complex ligand binding models over very small time intervals by Euler's method. As input, they require only ligand concentration(s) and rate constants.
KEY
Results
Compared to often-complex algebraic expressions, binding fluxes allow more intuitive/inductive insight into different aspects of ligand binding such as the occurrence of transient binding overshoots and the effect of a closing lid over the ligand's binding pocket on ligand dissociation. These examples disclose fundamental principles that govern ligand binding and, above all, they highlight the essential role of rate constants in all the examined binding models.
Conclusions
AND IMPLICATIONS
Binding fluxes and rate constants complement each other: They respectively indicate how and why binding processes evolve in a certain fashion. The presented flux-based approaches have the advantage to address pre-equilibrium as well as equilibrium conditions and can be applied to any ligand-binding model.
When the rates of ligand binding are measured by methods such as surface plasmon resonance, it is common practice to use the observed rate constants for the onset and offset of binding to estimate an equilibrium constant for ligand binding. If this agrees with the equilibrium constant found as the EC50 for binding at e...
Predicting ligand efficacy is a critical challenge in drug discovery, as a target’s functional response is often determined by the way a ligand shifts conformational equilibria between different functional states, a process that is particularly intricate in ion channels. We classify ligands based on the difference of t...
Martin Vögele, A. Leffler, Kevin C. Felt et al.· bioRxiv· 0 citations
We present a statistical-mechanics framework for computing equilibrium binding constants $K$ in the dilute limit. From first principles, we derive a general expression relating $K$ to the relative populations of the bound and unbound states. Its transparency has twofold advantage: it makes the origin of the unbound-sta...
Davide Mandelli, E. Ippoliti, C. Plate· 0 citations
How NMR experiments characterize molecular recognition in protein–ligand interactions is discussed, which enables a workflow that accelerates the progression from initial binding identification to structural and dynamic characterization.
Hai-Qin Yao, Ning Xu· International Journal of Mol...· 0 citations
It is shown that inhibitor size and flexibility affect binding mechanisms and have implications on kinetics, distinct from previous computational studies.
A. Shinobu, Suyong Re, Hiraku Oshima et al.· Journal of Physical Chemistr...· 0 citations
A practical overview of classical atomistic MD methodologies commonly used in medicinal chemistry, including force-field-based simulations, enhanced sampling techniques, and free-energy calculation methods such as alchemical and end-point approaches are provided.
S. S. Çınaroğlu· Mini-Reviews in Medical Chem...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.